REFERENCES
- Mackay IR: The problem of persisting destructive disease of the liver. Gastroenterology 40: 617–626, May 1961
- Read AE, Sherlock S, Harrison CV: Active “juvenile” cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy. Gut 4: 378, 1963
- Sherlock S: Waldenström's chronic active hepatitis. Acta Med Scand 179: Suppl 445: 426, 1966
- Sarkany I: Juvenile cirrhosis and allergic capillaritis of the skin. A hepato-cutaneous syndrome. Lancet 2: 666, 1966
- Mistilis SP, Blackburn CR: Active chronic hepatitis. Am J Med 48: 484, 1970
- Golding PL, Mason AM: Renal tubular acidosis and autoimmune liver disease. Gut 12: 153, 1971
- Sherlock S: The immunology of liver disease. Am J Med 49: 693, 1970
- Doniach D, Roitt IM, Walker JG, et al: Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol 1: 237, 1966
- Cook GC, Mulligan R, Sherlock S: Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 40: 159, 1971
- Whelton MJ, Sherlock S: Pregnancy in patients with hepatic cirrhosis. Lancet 2: 995, 1968
- Sherlock S, Fox RA, Niazi SP, et al: Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet 1: 1243, 1970